National Bank of Canada FI Has $90.21 Million Stake in CME Group Inc. (NASDAQ:CME)

National Bank of Canada FI trimmed its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 31.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 340,110 shares of the financial services provider’s stock after selling 153,413 shares during the period. National Bank of Canada FI owned about 0.09% of CME Group worth $90,205,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bank Pictet & Cie Europe AG boosted its position in shares of CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider’s stock valued at $20,190,000 after acquiring an additional 19,533 shares in the last quarter. Advisory Services Network LLC boosted its position in shares of CME Group by 15.5% during the 4th quarter. Advisory Services Network LLC now owns 1,609 shares of the financial services provider’s stock valued at $374,000 after acquiring an additional 216 shares in the last quarter. Martingale Asset Management L P boosted its position in shares of CME Group by 8.8% during the 4th quarter. Martingale Asset Management L P now owns 12,004 shares of the financial services provider’s stock valued at $2,788,000 after acquiring an additional 973 shares in the last quarter. Scotia Capital Inc. boosted its position in shares of CME Group by 35.4% during the 4th quarter. Scotia Capital Inc. now owns 51,482 shares of the financial services provider’s stock valued at $11,958,000 after acquiring an additional 13,454 shares in the last quarter. Finally, Jaffetilchin Investment Partners LLC boosted its position in shares of CME Group by 13.9% during the 4th quarter. Jaffetilchin Investment Partners LLC now owns 2,937 shares of the financial services provider’s stock valued at $682,000 after acquiring an additional 359 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other news, Director Charles P. Carey sold 500 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director owned 4,900 shares of the company’s stock, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of the stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director owned 3,668 shares of the company’s stock, valued at $1,035,916.56. The trade was a 12.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,750 shares of company stock valued at $1,576,294 over the last three months. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Morgan Stanley lifted their target price on shares of CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a research report on Thursday, April 24th. Erste Group Bank lowered shares of CME Group from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 24th. Barclays set a $298.00 price target on shares of CME Group and gave the company an “equal weight” rating in a report on Thursday, July 24th. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a report on Thursday, April 24th. Finally, Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $261.93.

View Our Latest Analysis on CME

CME Group Stock Up 0.4%

Shares of CME stock opened at $282.21 on Friday. The firm has a fifty day moving average of $275.84 and a 200-day moving average of $265.67. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12-month low of $203.77 and a 12-month high of $290.79. The company has a market capitalization of $101.70 billion, a price-to-earnings ratio of 27.32, a P/E/G ratio of 4.99 and a beta of 0.44.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm earned $2.56 earnings per share. The firm’s revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio is 48.40%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.